Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Arbutus Biopharma Corporation Stock Price (Quote) NASDAQ:ABUS
$4.08 ( -1.69% ) Friday, 15th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $3.73 | $4.74 | Friday, 15th Oct 2021 ABUS stock ended at $4.08. This is 1.69% less than the trading day before Thursday, 14th Oct 2021. During the day the stock fluctuated 3.98% from a day low at $4.02 to a day high of $4.18. |
| 90 days | $2.57 | $4.74 | |
| 52 weeks | $2.43 | $5.87 |
Historical Arbutus Biopharma Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-15 | $4.18 | $4.18 | $4.02 | $4.08 | 2 200 547 |
| 2021-10-14 | $4.16 | $4.18 | $4.00 | $4.15 | 2 054 605 |
| 2021-10-13 | $4.25 | $4.33 | $4.06 | $4.16 | 3 315 023 |
| 2021-10-12 | $4.24 | $4.30 | $4.16 | $4.23 | 2 607 298 |
| 2021-10-11 | $3.90 | $4.21 | $3.84 | $4.20 | 2 742 755 |
| 2021-10-08 | $4.13 | $4.14 | $3.94 | $3.94 | 2 926 831 |
| 2021-10-07 | $4.29 | $4.42 | $3.73 | $4.10 | 10 113 795 |
| 2021-10-06 | $4.15 | $4.24 | $3.91 | $4.00 | 3 213 062 |
| 2021-10-05 | $4.17 | $4.26 | $4.12 | $4.19 | 1 286 475 |
| 2021-10-04 | $4.25 | $4.27 | $4.08 | $4.13 | 1 816 671 |
| 2021-10-01 | $4.27 | $4.29 | $4.06 | $4.28 | 1 823 739 |
| 2021-09-30 | $4.35 | $4.37 | $4.26 | $4.29 | 1 782 265 |
| 2021-09-29 | $4.35 | $4.39 | $4.16 | $4.27 | 2 451 138 |
| 2021-09-28 | $4.58 | $4.58 | $4.22 | $4.32 | 3 196 665 |
| 2021-09-27 | $4.73 | $4.74 | $4.53 | $4.62 | 2 776 186 |
| 2021-09-24 | $4.50 | $4.70 | $4.45 | $4.62 | 2 841 590 |
| 2021-09-23 | $4.59 | $4.64 | $4.42 | $4.53 | 2 460 862 |
| 2021-09-22 | $4.37 | $4.51 | $4.33 | $4.44 | 3 037 202 |
| 2021-09-21 | $4.31 | $4.45 | $4.26 | $4.37 | 2 122 544 |
| 2021-09-20 | $4.20 | $4.45 | $4.11 | $4.29 | 3 250 956 |
| 2021-09-17 | $4.36 | $4.37 | $4.15 | $4.35 | 2 791 811 |
| 2021-09-16 | $4.25 | $4.36 | $4.15 | $4.31 | 2 918 876 |
| 2021-09-15 | $4.14 | $4.26 | $4.14 | $4.22 | 2 013 058 |
| 2021-09-14 | $4.13 | $4.31 | $4.11 | $4.25 | 2 927 157 |
| 2021-09-13 | $4.35 | $4.39 | $4.06 | $4.25 | 5 294 721 |
| 2021-09-10 | $4.50 | $4.67 | $4.17 | $4.38 | 25 328 493 |
| 2021-09-09 | $3.34 | $3.90 | $3.34 | $3.87 | 5 619 403 |
| 2021-09-08 | $3.45 | $3.49 | $3.32 | $3.36 | 1 206 376 |
| 2021-09-07 | $3.43 | $3.48 | $3.37 | $3.43 | 741 879 |
| 2021-09-03 | $3.43 | $3.45 | $3.33 | $3.41 | 655 037 |
| 2021-09-02 | $3.45 | $3.52 | $3.41 | $3.44 | 1 048 457 |
| 2021-09-01 | $3.48 | $3.54 | $3.40 | $3.44 | 1 281 040 |
| 2021-08-31 | $3.40 | $3.48 | $3.36 | $3.43 | 1 044 940 |
| 2021-08-30 | $3.38 | $3.53 | $3.30 | $3.38 | 1 874 209 |
| 2021-08-27 | $3.28 | $3.38 | $3.23 | $3.33 | 1 041 274 |
| 2021-08-26 | $3.28 | $3.36 | $3.25 | $3.25 | 1 147 784 |
| 2021-08-25 | $3.22 | $3.35 | $3.18 | $3.26 | 1 190 783 |
| 2021-08-24 | $3.13 | $3.28 | $3.08 | $3.25 | 1 332 060 |
| 2021-08-23 | $3.01 | $3.17 | $2.98 | $3.11 | 1 091 603 |
| 2021-08-20 | $2.85 | $2.97 | $2.82 | $2.92 | 1 229 488 |
| 2021-08-19 | $2.94 | $2.99 | $2.86 | $2.87 | 842 062 |
| 2021-08-18 | $3.32 | $3.35 | $2.97 | $3.00 | 2 291 796 |
| 2021-08-17 | $2.80 | $3.35 | $2.78 | $3.32 | 4 549 898 |
| 2021-08-16 | $3.07 | $3.08 | $2.84 | $2.86 | 854 899 |
| 2021-08-13 | $3.10 | $3.13 | $3.03 | $3.07 | 811 839 |
| 2021-08-12 | $3.20 | $3.29 | $3.03 | $3.04 | 2 113 156 |
| 2021-08-11 | $3.22 | $3.27 | $3.10 | $3.19 | 1 437 964 |
| 2021-08-10 | $3.15 | $3.26 | $3.12 | $3.14 | 1 871 194 |
| 2021-08-09 | $3.07 | $3.23 | $3.04 | $3.09 | 1 756 373 |
| 2021-08-06 | $2.93 | $3.06 | $2.85 | $3.01 | 894 626 |
Arbutus Biopharma Corporation, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of chronic hepatitis B (HBV) infections in Canada and the United States. It also develops a pipeline of products based on RNA interference therapeutics (RNAi). Its lead candidate is ARB-1467, a multi-component RNAi therapeutic product that is designed for the elimination of HBV surface antigen expression in patients chronically i... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
